Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
On Feb. 5, 2018, a Federal Circuit panel of Judges Prost, Dyk, and Chen issued a unanimous opinion, authored by Judge Dyk, in AbbVie Inc. v. MedImmune Ltd., 881 F.3d 1334 (Fed. Cir. 2018). Despite finding that the district court relied on incorrect grounds, the panel affirmed the dismissal of the action without prejudice due to lack of declaratory-judgment jurisdiction.
Under an agreement that led to the development of the blockbuster antibody drug Humira, Abbvie was obligated to pay MedImmune royalties on sales of certain antibodies until “the last to expire of [certain] Patents or the expiry of fifteen years from the date of First Commercial Sale of a Product by [AbbVie's predecessor] … (whichever is later).” Id. at 1335. In hopes of ending its royalty obligations early, Abbvie brought a declaratory-judgment action in the Eastern District of Virginia, seeking a declaration that the sole patent-at-issue was invalid. While Abbvie argued that the patent's invalidity would constitute its expiration for purposes of the licensing agreement, it did not seek a declaration as to the contract's interpretation.
The district court dismissed Abbvie's action without prejudice on two grounds. First, it held that Abbvie lacked standing to bring a declaratory-judgment action because it was undisputed that Abbvie was not practicing the patent and, therefore, was not at risk of being sued for patent infringement. Second, it held that even if Abbvie had standing, deciding the dispute would implicate questions of foreign law and sovereign immunity because the licensing agreement was governed British law. The district court, therefore, declined to exercise its declaratory-judgment jurisdiction as a matter of discretion.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
UCC Sections 9406(d) and 9408(a) are one of the most powerful, yet least understood, sections of the Uniform Commercial Code. On their face, they appear to override anti-assignment provisions in agreements that would limit the grant of a security interest. But do these sections really work?